NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Adimab, Inc.



Adimab, Inc. Expands Scientific Advisory Board With Dr. Sachdev Sidhu



June 13th, 2008

Adimab, Inc. announces the addition of Dr. Sachdev Sidhu to its scientific advisory board. Dr. Sidhu recently joined the faculty in the Banting and Best Department of Medical Research at the University of Toronto. Professor Sidhu returns to academia after a distinguished career at Genentech where he led the development of the company's phage display technology.

"At Genentech Dr. Sidhu made significant contributions and established himself as a recognized thought leader in the area of semi-synthetic antibody library design," said Dr. Tillman Gerngross, Adimab Chief Executive Officer and Co-founder. "He brings a wealth of experience in commercial antibody discovery and we...


Source: Health Business Week (2008-06-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login